New life in a sleeper: Thalidomide and Crohn's disease
- 1 December 1999
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 117 (6) , 1485-1488
- https://doi.org/10.1016/s0016-5085(99)70299-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Protein Kinase C–Dependent Effects on Leukocyte Migration of ThalidomideThe Journal of Infectious Diseases, 1999
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Thalidomide in Crohn's diseaseThe Lancet, 1997
- Thalidomide may impede cell migration in primates by down-regulating integrin β-chains: potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosisMedical Hypotheses, 1997
- Regression of AIDS-Related Kaposi's Sarcoma During Therapy with ThalidomideClinical Infectious Diseases, 1996
- Prurigo nodularis and photosensitivity in AIDS: Treatment with thalidomideJournal of the American Academy of Dermatology, 1995
- Treatment of cutaneous and pulmonary sarcoidosis with thalidomideJournal of the American Academy of Dermatology, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Treatment of ulcerative colitis with thalidomide.BMJ, 1979